Company profile for Full-Life Technologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Full-Life technologies limited (“Full-Life”) is a fully integrated global Nuclear Health company headquartered in Shanghai with operations in Europe. We seek to own the entire value chain for radio-ligand production, research, development and commercialization in order to deliver clinical impact for patients. Our core platform seeks to attack the two core issues that exist in radiopharmaceuticals today: 1) the ability to p...
Full-Life technologies limited (“Full-Life”) is a fully integrated global Nuclear Health company headquartered in Shanghai with operations in Europe. We seek to own the entire value chain for radio-ligand production, research, development and commercialization in order to deliver clinical impact for patients. Our core platform seeks to attack the two core issues that exist in radiopharmaceuticals today: 1) the ability to produce in high quality and quantity radioisotope to meeting tomorrow’s needs and 2) innovative translational and biology research platform targeting the radio-pharma treatments of tomorrow.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Room A1306, 13th Floor, Building 3 No. 702, Zhongke Road Shanghai
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/full-life-technologies-announces-us77-million-financing-to-accelerate-development-of-its-radiopharmaceutical-pipeline-and-manufacturing-capabilities-302569126.html

PR NEWSWIRE
30 Sep 2025

https://www.prnewswire.com/news-releases/full-life-technologies-announces-the-appointment-of-edward-ted-myles-to-its-board-of-directors-302202131.html

PR NEWSWIRE
21 Jul 2024

https://www.prnewswire.com/news-releases/full-life-technologies-sk-biopharmaceuticals-enter-licensing-agreement-for-novel-therapeutic-targeting-multiple-solid-tumors-302197884.html

PR NEWSWIRE
17 Jul 2024

https://www.fiercebiotech.com/biotech/sk-inks-572m-deal-full-life-prospect-advancing-push-become-asias-radiopharma-leader

FIERCE BIOTECH
17 Jul 2024

https://www.pharmabiz.com/NewsDetails.aspx?aid=170115&sid=2

PHARMABIZ
04 Jul 2024

https://www.prnewswire.com/news-releases/full-life-technologies-granted-fda-fast-track-designation-for-225ac-fl-020-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-302186673.html

PR NEWSWIRE
02 Jul 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty